Elsevier

Mitochondrion

Volume 54, September 2020, Pages 92-101
Mitochondrion

Mitochondrial chaperone, TRAP1 modulates mitochondrial dynamics and promotes tumor metastasis

https://doi.org/10.1016/j.mito.2020.08.001Get rights and content

Highlights

Abstract

Mitochondria play a central role in regulating cellular energy metabolism. However, the present understanding of mitochondria has changed from its unipotent functions to pluripotent and insists on understanding the role of mitochondria not only in regulating the life and death of cells, but in pathological conditions such as cancer. Unlike other cellular organelles, subtle alterations in mitochondrial organization may significantly influence the balance between metabolic networks and cellular behavior. Therefore, the delicate balance between the fusion and fission dynamics of mitochondrion can indicate cell fate. Here, we present mitochondrial chaperone TRAP1 influence on mitochondrial architecture and its correlation with tumor growth and metastasis. We show that TRAP1 overexpression (TRAP1 OE) promotes mitochondrial fission, whereas, TRAP1 knockdown (TRAP1 KD) promotes mitochondrial fusion. Interestingly, TRAP1 OE or KD had a negligible effect on mitochondrial integrity. However, TRAP1 OE cells exhibited enhanced proliferative potential, while TRAP1 KD cells showing increased doubling time. Further, TRAP1 dependent mitochondrial dynamic alterations appeared to be unique since mitochondrial localization of TRAP1 is a mandate for dynamic changes. The expression patterns of fusion and fission genes have failed to correlate with TRAP1 expression, indicating a possibility that the dynamic changes can be independent of these genes. In agreement with enhanced proliferative potential, TRAP1 OE cells also exhibited enhanced migration in vitro and tumor metastasis in vivo. Further, TRAP1 OE cells showed altered homing properties, which may challenge site-specific anticancer treatments. Our findings unravel the TRAP1 role in tumor metastasis, which is in addition to altered energy metabolism.

Introduction

Against the conventional understanding that mitochondria are powerhouses of cells, the emerging studies on mitochondria suggest that they are involved in regulating several cellular functions. Mitochondria are capable of going through fusion or fission in response to various intracellular or extracellular signals, indicating that they exist in a dynamic state between these two forms (Bereiter-Hahn and Voth, 1994, Youle and van der Bliek, 2012, Lee and Yoon, 2016). While maintenance of mitochondrial dynamics are under the regulatory control of membrane-associated GTPases (Thompson, 2002, Tilokani et al., 2018), the disruption of the mitochondrial network can promote apoptosis (Suen et al., 2008, Leboucher et al., 2012, Pyakurel et al., 2015). Mitochondrial dynamics play essential roles in cell cycle regulation (Horbay and Bilyy, 2016), differentiation (Seo et al., 2018), spermatogenesis (Honda and Hirose, 2003), immune metabolism (Angajala et al., 2018), calcium homeostasis (Kowaltowski et al., 2019) and many more. The exposure of cells to nutrient starvation induces mitochondrial fusion (Chang et al., 2019), while exposure to oxidative stress results in mitochondrial fission (Yu et al., 2019). In gross terms, mitochondrial dynamics appear to correlate with the functional state of cells.

The alterations in mitochondrial dynamics also correlate with pathological states (El-Hattab et al., 2018). These include diabetes (Fealy et al., 2018, Dube et al., 2020), cardiovascular diseases (Carreira et al., 2011, Dorn, 2016, Ong and Hausenloy, 2017), and cancer (Cuyas et al., 2018, Anderson et al., 2018, Han et al., 2018). Mitochondria are considered to be obsolete for cancer cells as they sustain oxygen deprivation despite compromised mitochondrial oxidative phosphorylation (OXPHOS) by activating alternate energy metabolism (Warburg et al., 1927, Solaini et al., 2011, Zhang and Yang, 2013). It is in agreement with Warburg’s hypothesis that cancer cells switch to glycolysis in the compromise of OXPHOS (Lebelo et al., 2019, Lu et al., 2015). Interestingly, the Warburg’s theory does not discuss the details of mitochondrial fate during the metabolic switch over. The assumptions include that dysfunctional mitochondria favors cancer progression, thus acts as a trigger for a metabolic switch over (Senyilmaz and Telema, 2015), and enforced OXPHOS inhibition triggers autophagy, a catabolic process (Daskalakis et al., 2020, Maes and Agostinis, 2014). The deregulated balance between fission–fusion dynamics of mitochondria also contributes to dysfunctional mitochondria (Chen and Chan, 2017). Since mitochondrial fusion facilitates ATP production by keeping tricarboxylic acid cycle (TCA) and OXPHOS in loop, mitochondrial fission thought to disconnect TCA and OXPHOS and sensitizes mitochondria to oxidative stress leading to autophagy or apoptosis (Yao et al., 2019).

Among the Hsp90 family of chaperones, Hsp90 predominantly contributes to tumor progression, which is due to its ability to stabilize the functions of mutated proteins, especially the oncogenic kinases (Sreedhar et al., 2004, Citri et al., 2006). While endoplasmic reticulum chaperone, Grp94 contributes to unfolded protein response (ERUPR) and host immunity (Li et al., 2019), its mitochondrial homolog, TRAP1 functions are not precise. Meanwhile, the TRAP1 role in tumor progression is emerging, and it is implicated in metabolic reprogramming (Masgras et al., 2017, Ramkumar et al., 2020). The TRAP1 involvement in mitochondrial fate determination and cancer progression are reported independently (Takamura et al., 2012, Zhang et al., 2015). Since mitochondria are sensitive to the alterations in cellular redox homeostasis, calcium, and protein homeostasis, these processes may have a considerable influence on mitochondrial dynamics.

Earlier, we showed that TRAP1 overexpression triggers the cellular metabolism despite dysfunctional OXPHOS (Ramkumar et al., 2020). In the present study, we have extended our study to understand how mitochondrial dynamics link TRAP1 to tumor progression. We demonstrate that TRAP1 overexpression induces mitochondrial fission while TRAP1 knockdown favors mitochondrial fusion. We present the involvement of TRAP1 in regulating mitochondrial dynamics and tumor metastasis. Since the interest in understanding the mitochondria role in tumor progression is continuously increasing, our findings gain importance.

Section snippets

Cell culture maintenance and treatments

Human neuroblastoma IMR-32 (ATCC® CCL127™) cells were obtained from American Type Culture Collection (ATCC). Cells were authenticated at the tissue culture facility of the institute, and maintained in Dulbecco’s Modified Eagle Medium (DMEM;# 12491-023; Thermo Fisher Scientifics) supplemented with 10% fetal bovine serum (FBS; # 12483-020; Thermo Fisher Scientifics) and antibiotics (600 µg/mL Penicillin; 500 μg/mL Streptomycin; 300 µg/mL Kanamycin) at 37 °C in a CO2 incubator. IMR-32 cells stably

The exogenous expression of TRAP1 show mitochondrial accumulation, enhanced cell proliferation, however, has a negligible effect on mitochondrial integrity

Towards understanding the functional role of TRAP1 in tumor cells, we first examined the effect of enforced TRAP1expression and knockdown on tumor cell proliferation and mitochondrial integrity in IMR-32 cells. The IMR-32 cells stably transfected with TRAP1 expression (TRAP1 OE) and TRAP1 knockdown (TRAP1 KD) systems were used and compared with parental cells (Ramkumar et al., 2020). The exogenous expression of TRAP1 (TRAP1 OE) showed enhanced mitochondrial accumulation (Fig. 1a) and correlated

Discussion

The theory of metabolic plasticity and Warburg’s hypothesis indicates that mitochondria are not obsolete but retains some of their functions and thus make them one of the hallmarks of cancer (Cannino et al., 2018, Porporato et al., 2018, Giampazolias and Tait, 2016). Therefore, understanding the mitochondrial dynamic alterations and their correlation with disease progression is suggested to be important (Bahat and Gross, 2019, Altieri, 2019; Khacho et al., 2016). In support of this,

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

Authors thank Mr. Harikrishna for electron microscopy experiments, Dr. Jerald Mahesh Kumar and Mr. Jedy Jose for animal experiments. Mr. Sandeep Porandla and Mr. Mitesh Shrestha are acknowledged for their help in cloning fusion and fission genes, also acknowledge Mrs. Mounika Guntipally for helping with initial animal handling. Authors thank Department of Science and Technology, Ministry of Science, Government of India for the financial support. Mr. Shrikant is supported by a fellowship from

References (70)

  • S. Honda et al.

    Stage-specific enhanced expression of mitochondrial fusion and fission factors during spermatogenesis in rat testis

    Biochim. Biophys. Res. Commun.

    (2003)
  • M. Khacho et al.

    Mitochondrial Dynamics Impacts Stem Cell Identity and Fate Decisions by Regulating a Nuclear Transcriptional Program

    Cell Stem Cell

    (2016)
  • G.P. Leboucher et al.

    Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis

    Mol Cell.

    (2012)
  • J. Lu et al.

    The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism

    Cancer Lett.

    (2015)
  • H. Maes et al.

    Autophagy and mitophagy interplay in melanoma progression

    Mitochondrion

    (2014)
  • G.L. Moldovan et al.

    PCNA, the maestro of the replication fork

    Cell

    (2007)
  • S.Y. Park et al.

    Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase

    J. Biol. Chem.

    (2004)
  • A. Pyakurel et al.

    Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis

    Mol. Cell.

    (2015)
  • B. Ramkumar et al.

    Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism

    Mitochondrion

    (2020)
  • S. Rovira-Llopis et al.

    Mitochondrial dynamics in type 2 diabetes: pathophysiological implications

    Redox Biol.

    (2017)
  • A.S. Sreedhar et al.

    Inhibition of Hsp90: a new strategy for inhibiting protein kinases

    Biochim. Biophys. Acta.

    (2004)
  • N.G. Vykuntham et al.

    Altered molecular pathways decides the treatment outcome of Hsp90 inhibitors against breast cancer cells

    Toxicol. In Vitro

    (2020)
  • Y. Zhang et al.

    Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention

    Cancer Biol. Ther.

    (2013)
  • D.C. Altieri

    Mitochondrial dynamics and metastasis

    Cell. Mol. Life Sci.

    (2019)
  • G.R. Anderson et al.

    Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors

    Nat. Commun.

    (2018)
  • S. Andrzejewski et al.

    Metformin directly acts on mitochondria to alter cellular bioenergetics

    Cancer Metab.

    (2014)
  • A. Angajala et al.

    Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism

    Front. Immunol.

    (2018)
  • J. Bereiter-Hahn et al.

    Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria

    Microsc. Res. Tech.

    (1994)
  • A.H. Bild et al.

    Oncogenic pathway signatures in human cancers as a guide to targeted therapies

    Nature

    (2006)
  • G. Cannino et al.

    Metabolic plasticity of tumor cell mitochondria

    Front. Oncol.

    (2018)
  • R.S. Carreira et al.

    Mitochondrial therapeutics for cardioprotection

    Curr. Pharm. Des.

    (2011)
  • J.Y. Chang et al.

    Melatonin affects mitochondrialfission/fusion dynamics in the diabetic retina

    J. Diabetes Res.

    (2019)
  • E. Cuyas et al.

    Mitostemness

    Cell Cycle

    (2018)
  • K. Daskalakis et al.

    Increasedautophagy/mitophagy levels in primary tumors of patients with pancreatic neuroendocrine neoplasms

    Endocrine

    (2020)
  • E. Daudigeos-Dubus et al.

    Establishment and characterization of new orthotopic and metastatic neuroblastoma models

    In Vivo

    (2014)
  • Cited by (19)

    • Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

      2022, Drug Resistance Updates
      Citation Excerpt :

      For example, the CCRF-CEM cells with a triple mutant of EZH2 (p.Gly159_Asp160del, p.Lys156fsX4 and p.Tyr153X that located in D1 domain) caused low protein levels of EZH2 and loss of EZH2 enzymatic activity. As shown in the lower right of Fig. 3B, depletion of the EZH2 in cells can promote expression of the mitochondrial chaperone TRAP1 via up-regulation of its target CRIP2, thus conferring resistance to chemotherapy (such as dexamethasone, doxorubicin, and vincristine)-induced mitochondrial apoptosis (Fig. 3B) (Bhola et al., 2016; Cheung et al., 2011; Purushottam Dharaskar et al., 2020). These results imply that targeting either the SET domain via small molecules or disrupting the EED (embryonic ectoderm development)/EZH2 interaction via peptides may be viable drug discovery strategies for second-generation EZH2 inhibitors (Anwar et al., 2021).

    • Hsp90 and its mitochondrial homologue TRAP-1 independently regulate hypoxia adaptations in Caenorhabditis elegans

      2021, Mitochondrion
      Citation Excerpt :

      Earlier, we demonstrated that enhanced TRAP-1 expression correlates with cancer progression (Ramkumar et al., 2020). We also described TRAP-1-mediated mitochondrial alterations contributing to alternate energy metabolism and disease progression (Purushottam Dharaskar et al., 2020). Cancer is a proliferation-linked polygenic disease and is majorly associated with hypoxia (Luoto et al., 2013).

    • Soy isoflavones, mitochondria and cell fate

      2021, Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health
    View all citing articles on Scopus
    View full text